271. 強直性脊椎炎 Ankylosing spondylitis Clinical trials / Disease details

臨床試験数 : 574 / 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146

diseases per page:

Showing 1 to 10 of 574 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05666115 (ClinicalTrials.gov)	January 2, 2023	22/11/2022	Efficacy of Modification of Lifestyle in the Treatment of Ankylosing Spondylitis: a Pilot Study	Efficacy of Modification of Lifestyle in the Treatment of Ankylosing Spondylitis	Arthritis;Rheumatic Diseases;Autoimmune Diseases	Dietary Supplement: Probiotic group;Other: Exercise group	Camilo Jose Cela University	NULL	Active, not recruiting	18 Years	60 Years	All	12	N/A	Spain
2	ITMCTR2200006601	2022-09-15	2022-09-15	Observation of curative effect of Du-moxibustion on patients with active ankylosing spondylitis	Clinical evaluation and mechanism study of moxibustion on Du meridian in the treatment of active ank ...	ankylosing spondylitis	healthy group:Oral celecoxib;therapy group:Du-Moxibustion (Moxibustion of Governor Vessel);	Affiliated Hospital of Shandong University of Traditional Chinese Medicine	NULL	Recruiting	18	60	Both	healthy group:30;therapy group:30;		China
3	NCT05407246 (ClinicalTrials.gov)	June 24, 2022	30/5/2022	Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis	A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study on the Efficacy ...	Active Ankylosing Spondylitis	Drug: Hemay005	Tianjin Hemay Pharmaceutical Co., Ltd	NULL	Not yet recruiting	18 Years	65 Years	All	90	Phase 2	China
4	NCT05427942 (ClinicalTrials.gov)	June 3, 2022	17/6/2022	Yuflyma® (Adalimumab), Patient Experience After Switching	YUflyma® (Adalimumab), Patient Experience After Switching to adaliMumab biosimilAr High concenTratio ...	Rheumatoid Arthritis;Ankylosing Spondylarthritis;Axial Spondyloarthritis Without Radiographic Eviden ...	Drug: Adalimumab	Celltrion HealthCare France	NULL	Recruiting	18 Years	N/A	All	300		France
5	NCT05527444 (ClinicalTrials.gov)	March 15, 2022	6/5/2022	The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylit ...	The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylit ...	Ankylosing Spondylitis	Drug: Secukinumab 150 mg/ml;Drug: Adalimumab Ab;Drug: NSAID;Drug: Thalidomide Pill	Qilu Hospital of Shandong University	NULL	Recruiting	18 Years	65 Years	All	100	Phase 4	China
6	NCT05379049 (ClinicalTrials.gov)	March 1, 2022	7/5/2022	Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis. ...	Evaluation of the Therapeutic Response to TNF-alpha Antagonist (Etanercept, Infliximab, Adalimumab) ...	Rheumatoid Arthritis;Inflammatory Arthritis;Ankylosing Spondylitis	Biological: Infliximab : Adalimumab; Etanercept	University of Sulaimani	NULL	Recruiting	18 Years	N/A	All	80		Iraq
7	NCT05164198 (ClinicalTrials.gov)	January 15, 2022	8/11/2021	Multicenter, Prospective Clinical Trial for Optimizing TNF Inhibitor Dose Adjustment in Ankylosing S ...	Multicenter, Prospective Clinical Trial for Optimizing TNF Inhibitor Dose Adjustment in Ankylosing S ...	Ankylosing Spondylitis;Axial Spondyloarthritis	Biological: Adalimumab and its biosimilars;Biological: Biological: Etanercept and its biosimilars;Biol ...	Hanyang University Seoul Hospital	Linical Korea	Not yet recruiting	18 Years	65 Years	All	448	Phase 4	NULL
8	NCT04876781 (ClinicalTrials.gov)	January 12, 2022	20/4/2021	Korean Post-marketing Surveillance for Xeljanz XR	Korean Post-marketing Surveillance for Xeljanz XR (Registered)	Active Moderate to Severe Rheumatoid Arthritis;Active Ankylosing Spondylitis	Drug: Tofacitinib XR	Pfizer	NULL	Recruiting	18 Years	N/A	All	200		Korea, Republic of
9	ChiCTR2100054201	2022-01-01	2021-12-11	Effectiveness and Economic Evaluation of Intervention in Chinese Patients with Active Ankylosing Spo ...	Effectiveness and Economic Evaluation of Intervention in Chinese Patients with Active Ankylosing Spo ...	Ankylosing Spondylitis	Intervention group:Etanercept25mg each time, twice a week, with an interval of 3-4 days;Control grou ...	West China Hospital of Sichuan University	NULL	Recruiting			Both	Intervention group:3000;Control group:1000;	N/A	China
10	NCT04924270 (ClinicalTrials.gov)	January 2022	7/6/2021	Safety and Efficacy of Faecal Microbiota Transplantation in Treatment-naïve Patients With Newly Diag ...	Safety and Clinical Efficacy Associated With Faecal Microbiota Transplantation Performed in Treatmen ...	Rheumatoid Arthritis;Reactive Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis;Gouty Arthritis;P ...	Biological: Faecal microbiota transplantation;Other: Placebo	Torkell Ellingsen	Region of Southern Denmark;University of Southern Denmark	Not yet recruiting	18 Years	70 Years	All	200	Phase 2	NULL

First Previous1 2 3 4 5…58Next Last